FDA Accepts sNDA for Furosemide (Furoscix) in Chronic Kidney Disease
HCPLive
JULY 25, 2024
The sNDA for furosemide seeks to expand the indication to include the treatment of edema due to fluid overload in patients with CKD, with a PDUFA date of March 6, 2025.
Let's personalize your content